Stryker Stock

Stryker Equity 2025

Stryker Equity

20.63 B USD

Ticker

SYK

ISIN

US8636671013

WKN

864952

In 2025, Stryker's equity was 20.63 B USD, a 10.98% increase from the 18.59 B USD equity in the previous year.

Stryker Aktienanalyse

What does Stryker do?

Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Stryker's Equity

Stryker's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Stryker's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Stryker's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Stryker's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Stryker’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Stryker stock

What is the equity of Stryker this year?

Stryker has equity of 20.63 B USD this year.

What was the equity of Stryker compared to the previous year?

The equity of Stryker has increased/decreased by 10.98% increased compared to the previous year.

What impact does a high equity have on investors of Stryker?

A high equity is advantageous for investors of Stryker as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Stryker?

A low equity can be a risk for investors of Stryker, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Stryker affect the company?

An increase in equity of Stryker can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Stryker affect the company?

A reduction in equity of Stryker can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Stryker?

Some factors that can affect the equity of Stryker include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Stryker so important for investors?

The equity of Stryker is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Stryker take to change the equity?

To change equity, Stryker can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Stryker pay?

Over the past 12 months, Stryker paid a dividend of 3.24 USD . This corresponds to a dividend yield of about 0.86 %. For the coming 12 months, Stryker is expected to pay a dividend of 7.43 USD.

What is the dividend yield of Stryker?

The current dividend yield of Stryker is 0.86 %.

When does Stryker pay dividends?

Stryker pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Stryker?

Stryker paid dividends every year for the past 35 years.

What is the dividend of Stryker?

For the upcoming 12 months, dividends amounting to 7.43 USD are expected. This corresponds to a dividend yield of 1.97 %.

In which sector is Stryker located?

Stryker is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stryker kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stryker from 10/31/2025 amounting to 0.84 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2025.

When did Stryker pay the last dividend?

The last dividend was paid out on 10/31/2025.

What was the dividend of Stryker in the year 2024?

In the year 2024, Stryker distributed 3.05 USD as dividends.

In which currency does Stryker pay out the dividend?

The dividends of Stryker are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Stryker stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Stryker

Our stock analysis for Stryker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stryker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.